T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response

Trends in Immunology

Volumn 30, Issue 3, 2009, Pages 102-108

  Sitkovsky, Michail V ^a,b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; CYCLIC AMP; HYPOXIA INDUCIBLE FACTOR 1ALPHA; T LYMPHOCYTE RECEPTOR;

ARTICLE; CYCLIC AMP RESPONSIVE ELEMENT; DNA STRUCTURE; EFFECTOR CELL; HUMAN; HYPOXIA; HYPOXIA RESPONSE ELEMENT; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; OXYGEN TENSION; PROTECTION; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ADENOSINE; ANIMALS; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; T-LYMPHOCYTES, REGULATORY;

EID: 61349158530     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.12.002     Document Type: Article

References (55)

1. Sakaguchi S., et al. Regulatory T cells and immune tolerance. Cell 133 (2008) 775-787
2. Lund J.M., et al. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320 (2008) 1220-1224
3. Paust S., et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10398-10403
4. Wing K., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322 (2008) 271-275
5. Perez N., et al. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. J. Immunol. 180 (2008) 6566-6576
6. Ko K., et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med. 202 (2005) 885-891
7. Ménard C., et al. Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?. Clin. Cancer Res. 14 (2008) 5242-5249
8. Hill J.A., et al. Foxp3 transcription-factor-dependent and -independenT regulation of the regulatory T cell transcriptional signature. Immunity 27 (2007) 786-800
9. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
10. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
11. Sitkovsky M., and Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1alpha and adenosine receptors. Nat. Rev. Immunol. 5 (2005) 712-721
12. Fredholm B.B., et al. Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 83 (2007) 263-276
13. Hasko G., et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7 (2008) 759-770
14. Caldwell C.C., et al. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167 (2001) 6140-6149
15. Kong T., et al. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10440-10445
16. Ohta A., et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13132-13137
17. Montesinos M.C., et al. Wound healing is accelerated by agonists of A2 (G alpha s-linked) receptors. J. Exp. Med. 186 (1997) 1615-1620
18. Lappas C.M., et al. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203 (2006) 2639-2648
19. Yang D., et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116 (2006) 1913-1923
20. Fredholm B.B., et al. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 385-412
21. Newby A.C., et al. Adenosine: a retaliatory metabolite or not?. News Physiol. Sci. 5 (1990) 67-70
22. Kobie J.J., et al. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J. Immunol. 177 (2006) 6780-6786
23. Deaglio S., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204 (2007) 1257-1265
24. Borsellino G., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 (2007) 1225-1232
25. Semenza G.L. Hypoxia and cancer. Cancer Metastasis Rev. 26 (2007) 223-224
26. Lukashev D., et al. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 177 (2006) 4962-4965
27. Thiel M., et al. Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2 (2007) e853
28. Kim H.P., and Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204 (2007) 1543-1551
29. Bosco M.C., et al. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration. Immunobiology 213 (2008) 733-749
30. Brenner S., et al. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 278 (2003) 5597-5604
31. Panther E., et al. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101 (2003) 3985-3990
32. Bopp T., et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204 (2007) 1303-1310
33. Saed G.M., et al. Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil. Steril. 75 (2001) 763-768
34. Platzer C., et al. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 29 (1999) 3098-3104
35. Chen Y.J., et al. Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J. Endocrinol. 192 (2007) 405-419
36. Jeon S.H., et al. Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J. Leukoc. Biol. 81 (2007) 557-566
37. Csoka B., et al. A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110 (2007) 2685-2695
38. Narravula S., et al. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J. Immunol. 165 (2000) 5262-5268
39. Ramanathan M., et al. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol. Biol. Cell 18 (2007) 14-23
40. De Ponti C., et al. Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J. Leukoc. Biol. 82 (2007) 392-402
41. Synnestvedt K., et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110 (2002) 993-1002
42. Thompson L.F., et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200 (2004) 1395-1405
43. Zheng Y., et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
44. Zarek P.E., et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111 (2008) 251-259
45. Ben-Shoshan J., et al. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur. J. Immunol. 38 (2008) 2412-2418
46. Neumann A.K., et al. Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17071-17076
47. Pandiyan P., et al. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol. 8 (2007) 1353-1362
48. Bodor J., et al. ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur. J. Immunol. 37 (2007) 884-895
49. Waldmann H. Tolerance can be infectious. Nat. Immunol. 9 (2008) 1001-1003
50. Wu Y., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
51. Rudensky A.Y., et al. FOXP3 and NFAT: partners in tolerance. Cell 126 (2006) 253-256
52. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
53. Rubartelli A., and Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 28 (2007) 429-436
54. Thiel M., et al. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3 (2005) e174
55. Ohta A., et al. 1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J. Immunol. 179 (2007) 7431-7438